Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy

References

• Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–7
   PubMed Web of Science ®Google Scholar
• Child J, Morgan G, Davies F, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New Engl J Med 2003; 348: 1875–83
   PubMed Web of Science ®Google Scholar
• Tricot G, Vesole DH, Jagannath S, et al. Graft-versus-myeloma effect: proof of principle. Blood 1996; 87: 1196–8
   PubMed Web of Science ®Google Scholar
• Reynolds C, Ratanatharathorn V, Adams P, et al. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma. Bone Marrow Transplant 2001; 27: 801–7
   PubMedGoogle Scholar
• Corradini P, Voena C, Tarella C, et al. Molecular and clinical remission in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol 1999; 17: 208–15
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Geyer SM, et al. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia 2004; 18: 1085–92
   PubMed Web of Science ®Google Scholar
• Kay NE, Leong TL, Bone N, et al. Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase III trial for newly diagnosed multiple myeloma patients. Blood 2001; 98: 23–8
   PubMed Web of Science ®Google Scholar
• Ito M, Shizuru J. Graft-vs-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model. Bio Blood Marrow Transplant 1999; 5: 357–68
   Google Scholar
• Rosinski SL, McNiece IK, Shpall EJ, et al. Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Bone Marrow Transplant 2005; 36: 425–30
   Google Scholar
• Hess AD, Bright EC, Thoburn C, et al. Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide. Blood 1997; 89: 2203–9
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Litzow MR, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res 2005; 11: 1210–18
   PubMed Web of Science ®Google Scholar
• Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298: 850–4
   PubMed Web of Science ®Google Scholar
• Dudley ME, Wunderlich JR, Nishirmura MI, et al. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 2001; 24: 363–73
   PubMed Web of Science ®Google Scholar
• Hu HM, Poehlein CH, Urba WJ, et al. Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res 2002; 62: 3914–9
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Inwards DJ, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 2001; 98: 579–85
   PubMed Web of Science ®Google Scholar
• Powles R, Singhal S, Treleaven J, et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 1998; 91: 3481–6
   PubMed Web of Science ®Google Scholar
• Pavletic ZS, Joshi SS, Pirruccello SJ, et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998; 21: 33–41
   PubMed Web of Science ®Google Scholar
• Wu J, Ernstoff MS, Hill JM, et al. Ex vivo expansion of non-MHC restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cytotherapy 2006; 8: 141–8
   PubMed Web of Science ®Google Scholar
• Verneris MR, Karami M, Baker J, et al. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood 2004; 103: 3065–72
   PubMed Web of Science ®Google Scholar
• Zea AH, Rodriguez PC, Atkins MB, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005; 65: 3044–8
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Quiceno DG, Zabaleta J, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004; 64: 5839–49
   PubMed Web of Science ®Google Scholar
• Wen WJ, Min R, Tricot G, et al. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Blood 2002; 99: 3280–5
   PubMed Web of Science ®Google Scholar
• Levine BL, Bernstein WB, Aronson NE, et al. Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med 2002; 8: 47–53
   PubMed Web of Science ®Google Scholar
• Laport GG, Levine BL, Stadtmauer EA, et al. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34 + -selected hematopoietic cell transplantation. Blood 2003; 102: 2004–13
   PubMed Web of Science ®Google Scholar
• de Gast GC, Vyth-Dreese FA, Nooijen W, et al. Re-infusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer. J Clin Oncol 2002; 20: 58–64
   PubMed Web of Science ®Google Scholar
• Rapoport AP, Levine BL, Badros A, et al. Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells. Bone Marrow Transplant 2004; 33: 53–60
   PubMed Web of Science ®Google Scholar